切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2018, Vol. 12 ›› Issue (02) : 105 -109. doi: 10.3877/cma.j.issn.1674-1358.2018.02.001

所属专题: 文献

综述

布鲁菌病研究进展
段毓姣1, 陈勇2, 孙华丽1, 窦唱1, 宋凯丽1, 徐艳利1, 蒋荣猛1, 李兴旺1,()   
  1. 1. 100015 北京,首都医科大学附属北京地坛医院感染感染性疾病诊治与研究中心
    2. 075000 张家口市,河北北方学院附属第一医感染科
  • 收稿日期:2017-03-01 出版日期:2018-04-15
  • 通信作者: 李兴旺

Research progress on brucellosis

Yujiao Duan1, Yong Chen2, Huali Sun1, Chang Dou1, Kaili Song1, Yanli Xu1, Rongmeng Jiang1, Xingwang Li1,()   

  1. 1. The National Clinical Department of Infectious diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
    2. The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China
  • Received:2017-03-01 Published:2018-04-15
  • Corresponding author: Xingwang Li
  • About author:
    Corresponding author: Li Xingwang, Email:
引用本文:

段毓姣, 陈勇, 孙华丽, 窦唱, 宋凯丽, 徐艳利, 蒋荣猛, 李兴旺. 布鲁菌病研究进展[J]. 中华实验和临床感染病杂志(电子版), 2018, 12(02): 105-109.

Yujiao Duan, Yong Chen, Huali Sun, Chang Dou, Kaili Song, Yanli Xu, Rongmeng Jiang, Xingwang Li. Research progress on brucellosis[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2018, 12(02): 105-109.

布鲁菌病是最常见的人畜共患病之一,呈全球范围流行,而我国近年来布鲁菌病发病率不断上升,给公众健康和社会经济带来的严重危害。布鲁菌病可以累及全身各个系统,若治疗不及时或不规范易复发或者呈现慢性化,甚至可以发生各种并发症而严重影响患者预后,故早诊断和早治疗至关重要。本文就布鲁菌病的病原学、流行现状、各系统临床表现以及实验室诊断和并发症的治疗进展进行综述。

Brucellosis is one of the most common zoonoses all over the world. In China, the incidence of human brucellosis has been rising continually, which brings a serious public health problem and socio-economic issue. Brucellosis can involve different systems, and can lead to relapse or chronicity if not treated timely and properly, and even a variety of complications which will seriously affect the prognosis of patients. So it is critical to diagnose and treat as early as impossible. This paper reviewed the current knowledge on etiology, epidemiology, clinical manifestations, laboratory diagnostics, different systemic complications and antibiotic therapy.

[1]
Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis[J]. Vet Microbiol,2010,140(3-4):392-398.
[2]
de Figueiredo P, Ficht TA, Rice-Ficht A, et al. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions[J]. Am J Pathol,2015,185(6):1505-1517.
[3]
Kurtaran B, Akyildiz O, Candevir Ulu A, et al. The relationship between brucellosis and vitamin D[J]. J Infect Dev Ctries,2016,10(2):176-182.
[4]
Zhong Z, Yu S, Wang X, et al. Human brucellosis in the People’s Republic of China during 2005-2010[J]. Int J Infect Dis,2013,17(5):e289-292.
[5]
Wang W, Liao Q, Wu X, et al. Potential risk of blood transfusion-transmitted brucellosis in an endemic area of China[J]. Transfusion,2015,55(3):586-592.
[6]
Kassiri H, Amani H, Lotfi M. Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran[J]. Asian Pac J Trop Biomed,2013,3(8):589-594.
[7]
Kose S, Serin Senger S, Akkoclu G, et al. Clinical manifestations, complications, and treatment of brucellosis: evaluation of 72 cases[J]. Turk J Med Sci,2014,44(2):220-223.
[8]
Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis[J]. PLoS Negl Trop Dis,2012,6(12):e1929.
[9]
Ulu-Kilic A, Metan G, Alp E. Clinical presentations and diagnosis of brucellosis[J]. Recent Pat Antiinfect Drug Discov,2013,8(1):34-41.
[10]
Buzgan T, Karahocagil MK, Irmak H, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature[J]. Int J Infect Dis,2010,14(6):e469-478.
[11]
Karabay O, Gozdas HT. Brucellar joint involvement presented with chest pain[J]. Indian J Med Res,2012,136(4):680.
[12]
Koubaa M, Maaloul I, Marrakchi C, et al. Spinal brucellosis in South of Tunisia: review of 32 cases[J]. Spine J,2014,14(8):1538-1544.
[13]
Aydemir H, Budak G, Budak S, et al. Different presentation types of primary Brucella epididimo-orchitis[J]. Arch Ital Urol Androl,2015,87(2):151-153.
[14]
Li J, Li Y, Wang Y, et al. Renal abscess caused by Brucella[J]. Int J Infect Dis,2014,28:26-28.
[15]
Sabanis N, Gavriilaki E, Paschou E, et al. Renal manifestations of human brucellosis: First report of minimal change disease[J]. Saudi J Kidney Dis Transpl,2016,27(3):590-594.
[16]
Wang WQ, Guo ZY. Brucella orchitis: A retrospective study of 69 cases[J]. Nat J Androl,2016,22(1):46-51.
[17]
Erdem H, Elaldi N, Ak O, et al. Genitourinary brucellosis: results of a multicentric study[J]. Clin Microbiol Infect,2014,20(11):847-853.
[18]
Karabakan M, Akdemir S, Akdemir AO, et al. A rare case of prostatic brucellosis mimicking prostate cancer[J]. Urol J,2014,11(6):1987-1988.
[19]
Ozturk-Engin D, Erdem H, Gencer S, et al. Liver involvement in patients with brucellosis: results of the Marmara study[J]. Eur J Clin Microbiol Infect Dis,2014,33(7):1253-1262.
[20]
Deveer M, Sozen H, Cullu N, et al. Splenic abscess due to acute brucellosis[J]. BMJ Case Rep,2013,2013.
[21]
Makaritsis KP, Liaskos C, Papadamou G, et al. Spontaneous bacterial peritonitis: an unusual manifestation of brucellosis in a previous healthy male patient[J]. BMJ Case Rep,2015,2015.
[22]
Barutta L, Ferrigno D, Melchio R, et al. Hepatic brucelloma[J]. Lancet Infect Dis,2013,13(11):987-993.
[23]
Erdem H, Inan A, Elaldi N, et al. Respiratory system involvement in brucellosis: the results of the Kardelen study[J]. Chest,2014,145(1):87-94.
[24]
Karsen H, Duygu F, Yapici K, et al. Severe thrombocytopenia and hemorrhagic diathesis due to brucellosis[J]. Arch Iran Med,2012,15(5):303-306.
[25]
Eskazan AE, Dal MS, Kaya S, et al. Two cases of autoimmune hemolytic anemia secondary to brucellosis: a review of hemolytic disorders in patients with brucellosis[J]. Internal Medicine,2014,53(11):1153-1158.
[26]
Aydin S, Gunal O, Taskin MH, et al. Brucellosis as a cause of hemophagocytic syndrome[J]. Mikrobiyol Bul,2015,49(2):292-294.
[27]
Karsen H, Tekin Koruk S, Duygu F, et al. Review of 17 cases of neurobrucellosis: clinical manifestations, diagnosis, and management[J]. Arch Iran Med,2012,15(8):491-494.
[28]
Cascio A, De Caridi G, Lentini S, et al. Involvement of the aorta in brucellosis: the forgotten, life-threatening complication. A systematic review[J]. Vector Borne Zoonotic Dis,2012,12(10):827-840.
[29]
Kaya S, Eskazan AE, Elaldi N. Brucellar pericarditis: a report of four cases and review of the literature[J]. Int J Infect Dis,2013,17(6):e428-e432.
[30]
Herrick JA, Lederman RJ, Sullivan B, et al. Brucella arteritis: clinical manifestations, treatment, and prognosis[J]. Lancet Infect Dis,2014,14(6):520-526.
[31]
Abid L, Frikha Z, Kallel S, et al. Brucella Myocarditis: A rare and life-threatening cardiac complication of Brucellosis[J]. Internal Medicine,2012,51(8):901-904.
[32]
Koubaa M, Frigui M, Cherif Y, et al. Deep vein thrombosis associated with acute brucellosis: a case report and review of the literature[J]. Korean J Intern Med,2013,28(5):628-630.
[33]
Mantur B, Parande A, Amarnath S, et al. ELISA versus conventional methods of diagnosing endemic brucellosis[J]. Am J Trop Med Hyg,2010,83(2):314-318.
[34]
Asaad AM, Alqahtani JM. Serological and molecular diagnosis of human brucellosis in Najran, Southwestern Saudi Arabia[J]. J Infect Public Health,2012,5(2):189-194.
[35]
Ahmed IM, Khairani-Bejo S, Hassan L, et al. Serological diagnostic potential of recombinant outer membrane proteins (rOMPs) from Brucella melitensis in mouse model using indirect enzyme-linked immunosorbent assay[J]. BMC Vet Res,2015,11(1):1-10.
[36]
Franco MP, Mulder M, Gilman RH, et al. Human brucellosis[J]. Lancet Infect Dis,2007,7(12):775-786.
[37]
Casanova A, Ariza J, Rubio M, et al. BrucellaCapt versus classical tests in the serological diagnosis and management of human brucellosis[J]. Clin Vaccine Immunol,2009,16(6):844-851.
[38]
Christopher S, Umapathy BL, Ravikumar KL. Brucellosis: review on the recent trends in pathogenicity and laboratory diagnosis[J]. J Lab Physicians,2010,2(2):55-60.
[39]
Peeridogaheh H, Golmohammadi MG, Pourfarzi F. Evaluation of ELISA and Brucellacapt tests for diagnosis of human Brucellosis[J]. Iran J Microbiol,2013,5(1):14-18.
[40]
Hekmatimoghaddam S, Sadeh M, Khalili MB, et al. Comparison of PCR, Wright agglutination test and blood culture for diagnosis of brucellosis in suspected patients[J]. Pak J Biol Sci,2013,16(22):1589-1592.
[41]
Solera J. Update on brucellosis: therapeutic challenges[J]. Int J Antimicrob Agents,2010,36(Suppl 1):S18-S20.
[42]
Al-Tawfiq JA, Memish ZA. Antibiotic susceptibility and treatment of brucellosis[J]. Recent Pat Antiinfect Drug Discov,2013,8(1):51-54.
[43]
Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial[J]. Int J Infect Dis,2012,16(4):e247-e251.
[44]
Vrioni G, Bourdakis A, Pappas G, et al. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load[J]. Antimicrobial Agents and Chemotherapy,2014,58(12):7541-7544.
[45]
Sofian M, Velayati AA, Aghakhani A, et al. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial[J]. Scand J Infect Dis,2014,46(8):573-577.
[46]
Al-Tawfiq JA, Memish ZA. Pregnancy associated brucellosis[J]. Recent Pat Antiinfect Drug Discov,2013,8(1):47-50.
[47]
Roushan MR, Amiri MJ. Update on childhood brucellosis[J]. Recent Pat Antiinfect Drug Discov,2013,8(1):42-46.
[48]
Lebre A, Velez J, Seixas D, et al. Brucellar spondylodiscitis: case series of the last 25 years[J]. Acta Med Port,2014,27(2):204-210.
[49]
Ulu-Kilic A, Karakas A, Erdem H, et al. Update on treatment options for spinal brucellosis[J]. Clin Microbiol Infect,2014,20(2):75-82.
[50]
Agarwal SK, Rajani AR, Hussain K, et al. Brucella endocarditis: an occupational hazard![J]. BMJ Case Rep,2013,2013.
[51]
Raju IT, Solanki R, Patnaik AN, et al. Brucella endocarditis--a series of five case reports[J]. Indian Heart J,2013,65(1):72-77.
[52]
Keshtkar-Jahromi M, Razavi SM, Gholamin S, et al. Medical versus medical and surgical treatment for brucella endocarditis[J]. Ann Thorac Surg,2012,94(6):2141-2146.
[53]
Turhan V, Salmanoglu M, Karagoz E, et al. Is antimicrobial treatment alone sufficient for Brucella endocarditis, and if it is, which antibiotics should we use?[J]. Int J Antimicrob Agents,2013,41(2):201-202.
[54]
Shetty RK, Madken M, Naha K, et al. Successful management of native-valve Brucella endocarditis with medical therapy alone[J]. BMJ Case Rep,2013,2013.
[55]
Zhao S, Cheng Y, Liao Y, et al. Treatment Efficacy and Risk Factors of Neurobrucellosis[J]. Med Sci Monit,2016,22:1005-1012.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[3] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[4] 中华医学会骨科学分会关节外科学组, 广东省医学会骨质疏松和骨矿盐疾病分会, 广东省佛山市顺德区第三人民医院. 中国髋部脆性骨折术后抗骨质疏松药物临床干预指南(2023年版)[J]. 中华关节外科杂志(电子版), 2023, 17(06): 751-764.
[5] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[6] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[7] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[9] 邱朋, 邓正栋, 王剑明. 肝内胆管结石微创治疗策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 591-596.
[10] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[11] 辛彩焕, 熊辉. 非疫区36例布鲁菌病患者的临床特征及诊疗分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 927-931.
[12] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要